Glucocorticoid Use and Risks of Ocular Hypertension and Glaucoma

JAMA: The Journal of the American Medical Association

Volumn 277, Issue 24, 1997, Pages 1929-

  Macris, Nicholas ^a  

^a LENOX HILL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; ANTIHISTAMINIC AGENT; BECLOMETASONE DIPROPIONATE;

CARDIOVASCULAR DISEASE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAOCULAR HYPERTENSION; NOTE; OPEN ANGLE GLAUCOMA; RISK; ANTICHOLINERGIC EFFECT; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLOSED ANGLE GLAUCOMA; DISEASE ASSOCIATION; DRUG MEGADOSE; GLAUCOMA; HIGH RISK POPULATION; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; AGED; CHEMICALLY INDUCED DISORDER;

ADMINISTRATION, INHALATION; CARDIOVASCULAR DISEASES; GLAUCOMA, OPEN-ANGLE; GLUCOCORTICOIDS; HUMANS; OCULAR HYPERTENSION; ODDS RATIO; AGED; ASTHMA;

EID: 0030905353     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03540480029019     Document Type: Letter

References (2)

1. Garbe E, LeLorier J, Boivin J-F, Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA. 1997;277:722-727.
2. National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md; National Institutes of Health; 1997.